No gainer or loser data available.

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

BlinkLab (ASX:BB1): Creating better tests to diagnose various neurodevelopmental conditions

Ahead of appearing at the Spark+ Australian Equities Day in Singapore, BlinkLab’s (ASX:BB1) Non-Executive Chairman Brian Leedman speaks with The Stock Network’s Lel Smits about:

📱 BlinkLab’s autism diagnostic test, technology development and near priorities
📱 Technology features and potential commercial outcomes

Watch the full interview ⚡️ https://www.youtube.com/watch?v=t7z7g9kUTvA
Register to attend Australian Equities Day: https://www.eventbrite.sg/e/spark-plus-australian-equities-day-tickets-939180011697